<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<title>S4545</title>
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:"Albertus Extra Bold";
	panose-1:2 14 8 2 4 3 4 2 2 4;}
@font-face
	{font-family:Marlett;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"Segoe UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.MsoCommentText, li.MsoCommentText, div.MsoCommentText
	{mso-style-link:"Comment Text Char";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:9.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	background:navy;
	font-size:12.0pt;
	font-family:"Tahoma",sans-serif;}
p.MsoCommentSubject, li.MsoCommentSubject, div.MsoCommentSubject
	{mso-style-link:"Comment Subject Char";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;
	font-weight:bold;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-link:"Balloon Text Char";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:9.0pt;
	font-family:"Segoe UI",sans-serif;
	letter-spacing:.2pt;}
span.11ptChar
	{mso-style-name:11ptChar;
	font-family:"Times New Roman",serif;}
span.BillHead
	{mso-style-name:BillHead;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.BillHeading2
	{mso-style-name:BillHeading2;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.BillHeadUnBold
	{mso-style-name:BillHeadUnBold;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
span.BillLanguage
	{mso-style-name:BillLanguage;
	font-family:"Times New Roman",serif;
	font-style:italic;}
p.bpuBill, li.bpuBill, div.bpuBill
	{mso-style-name:bpuBill;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:26.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuHeadSpon, li.bpuHeadSpon, div.bpuHeadSpon
	{mso-style-name:bpuHeadSpon;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.bpuHeadSponChar
	{mso-style-name:bpuHeadSponChar;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuIntro, li.bpuIntro, div.bpuIntro
	{mso-style-name:bpuIntro;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.bpuLegislature, li.bpuLegislature, div.bpuLegislature
	{mso-style-name:bpuLegislature;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:24.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuNormText, li.bpuNormText, div.bpuNormText
	{mso-style-name:bpuNormText;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuReprint, li.bpuReprint, div.bpuReprint
	{mso-style-name:bpuReprint;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:22.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.bpuSponsor, li.bpuSponsor, div.bpuSponsor
	{mso-style-name:bpuSponsor;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuState, li.bpuState, div.bpuState
	{mso-style-name:bpuState;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:32.0pt;
	font-family:"Arial",sans-serif;
	font-weight:bold;}
span.charMarlett
	{mso-style-name:charMarlett;
	font-family:Marlett;}
p.ElevenPt, li.ElevenPt, div.ElevenPt
	{mso-style-name:ElevenPt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPage, li.FronterPage, div.FronterPage
	{mso-style-name:FronterPage;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPage12pt, li.FronterPage12pt, div.FronterPage12pt
	{mso-style-name:FronterPage12pt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageBillHeading, li.FronterPageBillHeading, div.FronterPageBillHeading
	{mso-style-name:FronterPageBillHeading;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
p.FronterPageTBox2, li.FronterPageTBox2, div.FronterPageTBox2
	{mso-style-name:FronterPageTBox2;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageTextBox, li.FronterPageTextBox, div.FronterPageTextBox
	{mso-style-name:FronterPageTextBox;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.FronterSameAs, li.FronterSameAs, div.FronterSameAs
	{mso-style-name:FronterSameAs;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.HangingAnAct, li.HangingAnAct, div.HangingAnAct
	{mso-style-name:HangingAnAct;
	mso-style-link:"HangingAnAct Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.HangingAnActChar
	{mso-style-name:"HangingAnAct Char";
	mso-style-link:HangingAnAct;
	letter-spacing:.2pt;}
span.Para10pt
	{mso-style-name:Para10pt;
	font-family:"Times New Roman",serif;}
p.Pg2Footer, li.Pg2Footer, div.Pg2Footer
	{mso-style-name:Pg2Footer;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:8.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.StyleFronterPage11pt, li.StyleFronterPage11pt, div.StyleFronterPage11pt
	{mso-style-name:"Style FronterPage + 11 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.StyleFronterPageLoweredby3pt, li.StyleFronterPageLoweredby3pt, div.StyleFronterPageLoweredby3pt
	{mso-style-name:"Style FronterPage + Lowered by  3 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	position:relative;
	top:3.0pt;}
p.StyleFronterSameAsPatternSolid100White, li.StyleFronterSameAsPatternSolid100White, div.StyleFronterSameAsPatternSolid100White
	{mso-style-name:"Style FronterSameAs + Pattern\: Solid \(100%\) \(White\)";
	margin:0in;
	margin-bottom:.0001pt;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
span.Whereas
	{mso-style-name:Whereas;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.Style10pt
	{mso-style-name:"Style 10 pt";
	font-family:"Times New Roman",serif;}
p.FronterPageNOCAPS, li.FronterPageNOCAPS, div.FronterPageNOCAPS
	{mso-style-name:FronterPageNOCAPS;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuWpGraphic, li.bpuWpGraphic, div.bpuWpGraphic
	{mso-style-name:bpuWpGraphic;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.sponUdate, li.sponUdate, div.sponUdate
	{mso-style-name:sponUdate;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
span.fronterpagebillhead
	{mso-style-name:fronterpagebillhead;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
p.FPHangingAnAct, li.FPHangingAnAct, div.FPHangingAnAct
	{mso-style-name:FPHangingAnAct;
	mso-style-link:"FPHangingAnAct Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.4in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.FPHangingAnActChar
	{mso-style-name:"FPHangingAnAct Char";
	mso-style-link:FPHangingAnAct;
	letter-spacing:.2pt;}
span.LeftBrackt
	{mso-style-name:LeftBrackt;
	font-family:"Albertus Extra Bold",sans-serif;
	font-weight:bold;}
span.RightBrackt
	{mso-style-name:RightBrackt;
	font-family:"Albertus Extra Bold",sans-serif;
	font-weight:bold;}
span.BoldItal
	{mso-style-name:BoldItal;
	font-weight:bold;
	font-style:italic;}
p.HangingSup, li.HangingSup, div.HangingSup
	{mso-style-name:HangingSup;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.HangingTableBottom, li.HangingTableBottom, div.HangingTableBottom
	{mso-style-name:HangingTableBottom;
	margin-top:0in;
	margin-right:1.0in;
	margin-bottom:0in;
	margin-left:.8in;
	margin-bottom:.0001pt;
	text-indent:-.8in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.HangingTableTop, li.HangingTableTop, div.HangingTableTop
	{mso-style-name:HangingTableTop;
	margin-top:0in;
	margin-right:.5in;
	margin-bottom:0in;
	margin-left:.8in;
	margin-bottom:.0001pt;
	text-indent:-.8in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-link:"Balloon Text";
	font-family:"Segoe UI",sans-serif;
	letter-spacing:.2pt;}
span.CommentTextChar
	{mso-style-name:"Comment Text Char";
	mso-style-link:"Comment Text";
	letter-spacing:.2pt;}
span.CommentSubjectChar
	{mso-style-name:"Comment Subject Char";
	mso-style-link:"Comment Subject";
	letter-spacing:.2pt;
	font-weight:bold;}
.MsoChpDefault
	{font-size:10.0pt;}
 /* Page Definitions */
 @page WordSection1
	{size:8.5in 14.0in;
	margin:1.5in 1.0in 1.0in 1.0in;}
div.WordSection1
	{page:WordSection1;}
@page WordSection2
	{size:8.5in 14.0in;
	margin:1.0in 113.75pt 1.0in 113.75pt;}
div.WordSection2
	{page:WordSection2;}
@page WordSection3
	{size:8.5in 14.0in;
	margin:1.0in 1.75in 1.3in 2.0in;}
div.WordSection3
	{page:WordSection3;}
-->
</style>

</head>

<body lang=EN-US>

<div class=WordSection1>

<p class=bpuBill><a name=bpuFrontPg></a>SENATE, No. 4545 </p>

<p class=bpuWpGraphic><b><span style='font-size:32.0pt;line-height:120%;
font-family:"Arial",sans-serif;letter-spacing:0pt'>STATE OF NEW JERSEY</span></b></p>

<p class=bpuLegislature>221st LEGISLATURE</p>

<p class=bpuWpGraphic>  </p>

<p class=bpuIntro>INTRODUCED JUNE 2, 2025</p>

<p class=bpuIntro>&nbsp;</p>

</div>

<span style='font-size:11.0pt;line-height:120%;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:auto'>
</span>

<div class=WordSection2>

<p class=bpuIntro>&nbsp;</p>

<p class=bpuSponsor>Sponsored by:</p>

<p class=bpuSponsor>Senator  MICHAEL L. TESTA, JR.</p>

<p class=bpuSponsor>District 1 (Atlantic, Cape May and Cumberland)</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>Co-Sponsored by:</p>

<p class=bpuSponsor>Senators Burgess, Henry and Gopal</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>SYNOPSIS</p>

<p class=bpuNormText>     Expands epinephrine administration mechanisms
permitted in schools.</p>

<p class=bpuNormText>&nbsp;</p>

<p class=bpuSponsor>CURRENT VERSION OF TEXT </p>

<p class=bpuNormText>     As introduced.</p>

<p class=bpuNormText>   </p>

</div>

<span style='font-size:12.0pt;line-height:120%;font-family:"Times New Roman",serif;
letter-spacing:.2pt'><br clear=all style='page-break-before:always'>
</span>

<div class=WordSection3>

<p class=HangingAnAct style='line-height:150%'><span class=BillHead>An Act</span><span
class=HangingAnActChar> concerning the administration of epinephrine in schools
and amending P.L.1997, c.368.</span></p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     <span class=BillHeading2>Be It
Enacted </span><span class=BillLanguage>by the Senate and General Assembly of
the State of New Jersey:</span></p>

<p class=MsoNormal style='line-height:150%'><span class=BillLanguage>&nbsp;</span></p>

<p class=MsoNormal style='line-height:150%'><span class=BillLanguage><span
style='font-style:normal'>     1.    Section 1 of </span></span>P.L.1997, c.368<span
class=BillLanguage><span style='font-style:normal'> (C.18A:40-12.5) is amended
to read as follows:</span></span></p>

<p class=MsoNormal style='line-height:150%'><span class=BillLanguage><span
style='font-style:normal'>     1.    Each board of education or chief school
administrator of a nonpublic school shall develop a policy in accordance with
the guidelines established by the Department of Education pursuant to section 4
of P.L.2007, c.57 (C.18A:40-12.6a) for the emergency administration of
epinephrine via </span></span><span class=BillLanguage><b><span
style='font-family:"Albertus Extra Bold",sans-serif;font-style:normal'>[</span></b></span><span
class=BillLanguage><span style='font-style:normal'>a pre-filled auto-injector</span></span><span
class=BillLanguage><b><span style='font-family:"Albertus Extra Bold",sans-serif;
font-style:normal'>]</span></b></span><span class=BillLanguage><span
style='font-style:normal'> <u>an FDA approved</u> mechanism to a pupil for
anaphylaxis provided that:</span></span></p>

<p class=MsoNormal style='line-height:150%'><span class=BillLanguage><span
style='font-style:normal'>     a.     the parents or guardians of the pupil
provide to the board of education or chief school administrator of a nonpublic
school written authorization for the administration of the epinephrine;</span></span></p>

<p class=MsoNormal style='line-height:150%'><span class=BillLanguage><span
style='font-style:normal'>     b.    the parents or guardians of the pupil
provide to the board of education or chief school administrator of a nonpublic school
written orders from the physician or advanced practice nurse that the pupil
requires the administration of epinephrine for anaphylaxis;</span></span></p>

<p class=MsoNormal style='line-height:150%'><span class=BillLanguage><span
style='font-style:normal'>     c.     the board or chief school administrator
of a nonpublic school informs the parents or guardians of the pupil in writing
that the district and its employees or agents or the nonpublic school and its
employees or agents shall have no liability as a result of any injury arising
from the administration of the epinephrine via </span></span><span
class=BillLanguage><b><span style='font-family:"Albertus Extra Bold",sans-serif;
font-style:normal'>[</span></b></span><span class=BillLanguage><span
style='font-style:normal'>a pre-filled auto-injector</span></span><span
class=BillLanguage><b><span style='font-family:"Albertus Extra Bold",sans-serif;
font-style:normal'>]</span></b></span><span class=BillLanguage><span
style='font-style:normal'> <u>an FDA approved</u> mechanism;</span></span></p>

<p class=MsoNormal style='line-height:150%'><span class=BillLanguage><span
style='font-style:normal'>     d.    the parents or guardians of the pupil sign
a statement acknowledging their understanding that the district or the
nonpublic school shall have no liability as a result of any injury arising from
the administration of the epinephrine via </span></span><span
class=BillLanguage><b><span style='font-family:"Albertus Extra Bold",sans-serif;
font-style:normal'>[</span></b></span><span class=BillLanguage><span
style='font-style:normal'>a pre-filled auto-injector</span></span><span
class=BillLanguage><b><span style='font-family:"Albertus Extra Bold",sans-serif;
font-style:normal'>]</span></b></span><span class=BillLanguage><span
style='line-height:150%;font-style:normal'> <u>an</u> <u>FDA approved</u></span></span><span
class=BillLanguage><span style='font-style:normal'> mechanism to the pupil and
that the parents or guardians shall indemnify and hold harmless the district
and its employees or agents or the nonpublic school and its employees or agents
against any claims arising out of the administration of the epinephrine via </span></span><span
class=BillLanguage><b><span style='font-family:"Albertus Extra Bold",sans-serif;
font-style:normal'>[</span></b></span><span class=BillLanguage><span
style='font-style:normal'>a pre-filled auto-injector</span></span><span
class=BillLanguage><b><span style='font-family:"Albertus Extra Bold",sans-serif;
font-style:normal'>]</span></b></span><span class=BillLanguage><span
style='font-style:normal'> <u>an FDA approved </u>mechanism; and</span></span></p>

<p class=MsoNormal style='line-height:150%'><span class=BillLanguage><span
style='font-style:normal'>     e.     the permission is effective for the
school year for which it is granted and is renewed for each subsequent school
year upon fulfillment of the requirements in subsections a. through d. of this
section.</span></span></p>

<p class=MsoNormal style='line-height:150%'><span class=BillLanguage><span
style='font-style:normal'>     The policy developed by a board of education or
chief school administrator of a nonpublic school shall require:</span></span></p>

<p class=MsoNormal style='line-height:150%'><span class=BillLanguage><span
style='font-style:normal'>     (1)   the placement of a pupil's prescribed
epinephrine in a secure but unlocked location easily accessible by the school
nurse and designees to ensure prompt availability in the event of an allergic
emergency at school or at a school-sponsored function.  The location of the
epinephrine shall be indicated on the pupil's emergency care plan.  Back-up
epinephrine via </span></span><span class=BillLanguage><b><span
style='font-family:"Albertus Extra Bold",sans-serif;font-style:normal'>[</span></b></span><span
class=BillLanguage><span style='font-style:normal'>a pre-filled auto-injector</span></span><span
class=BillLanguage><b><span style='font-family:"Albertus Extra Bold",sans-serif;
font-style:normal'>]</span></b></span><span class=BillLanguage><span
style='line-height:150%;font-style:normal'> <u>an FDA</u> <u>approved</u></span></span><span
class=BillLanguage><span style='font-style:normal'> mechanism shall also be
available at the school if needed;</span></span></p>

<p class=MsoNormal style='line-height:150%'><span class=BillLanguage><span
style='font-style:normal'>     (2)   the school nurse or designee to be promptly
available on site at the school and school-sponsored functions in the event of
an allergic reaction; and</span></span></p>

<p class=MsoNormal style='line-height:150%'><span class=BillLanguage><span
style='font-style:normal'>     (3)   the transportation of the pupil to a
hospital emergency room by emergency services personnel after the
administration of epinephrine, even if the pupil's symptoms appear to have
resolved.</span></span></p>

<p class=MsoNormal style='line-height:150%'><span class=BillLanguage><span
style='font-style:normal'>     f.     The policy developed by a board of
education or chief school administrator of a nonpublic school shall also:</span></span></p>

<p class=MsoNormal style='line-height:150%'><span class=BillLanguage><span
style='font-style:normal'>     (1)   permit the school nurse or trained
designee to administer epinephrine via </span></span><span class=BillLanguage><b><span
style='font-family:"Albertus Extra Bold",sans-serif;font-style:normal'>[</span></b></span><span
class=BillLanguage><span style='font-style:normal'>a pre-filled auto-injector</span></span><span
class=BillLanguage><b><span style='font-family:"Albertus Extra Bold",sans-serif;
font-style:normal'>]</span></b></span><span class=BillLanguage><span
style='font-style:normal'> <u>an FDA approved</u> mechanism to any pupil
without a known history of anaphylaxis or any pupil whose parent or guardian
has not met the requirements of subsections a., b., and d. of this section and
has not received the notice required pursuant to subsection c. of this section
when the nurse or designee in good faith believes that the pupil is having an
anaphylactic reaction; and</span></span></p>

<p class=MsoNormal style='line-height:150%'><span class=BillLanguage><span
style='font-style:normal'>     (2)   require each public and nonpublic school
to maintain in a secure but unlocked and easily accessible location a supply of
</span></span><span class=BillLanguage><b><span style='font-family:"Albertus Extra Bold",sans-serif;
font-style:normal'>[</span></b></span><span class=BillLanguage><span
style='font-style:normal'>epinephrine auto-injectors</span></span><span
class=BillLanguage><b><span style='font-family:"Albertus Extra Bold",sans-serif;
font-style:normal'>]</span></b></span><span class=BillLanguage><span
style='font-style:normal'> <u>FDA approved epinephrine administration devices</u>
that is prescribed under a standing protocol from a licensed physician or an
advanced practice nurse, and is accessible to the school nurse and trained
designees for administration to a pupil having an anaphylactic reaction.</span></span></p>

<p class=MsoNormal style='line-height:150%'><span class=BillLanguage><span
style='font-style:normal'>(cf: P.L.2015, c.13, s.1)</span></span></p>

<p class=MsoNormal style='line-height:150%'><span class=BillLanguage><span
style='font-style:normal'>&nbsp;</span></span></p>

<p class=MsoNormal style='line-height:150%'><span class=BillLanguage><span
style='font-style:normal'>     2.    Section 2 of </span></span>P.L.1997, c.368<span
class=BillLanguage><span style='font-style:normal'> (C.18A:40-12.6) is amended
to read as follows:</span></span></p>

<p class=MsoNormal style='line-height:150%'><span class=BillLanguage><span
style='font-style:normal'>     2.    The policy for the administration of
medication to a pupil shall provide that the school nurse shall have the
primary responsibility for the administration of the epinephrine.  The school
nurse shall designate, in consultation with the board of education, or chief
school administrator of a nonpublic school additional employees of the school
district or nonpublic school who volunteer to administer epinephrine via </span></span><span
class=BillLanguage><b><span style='font-family:"Albertus Extra Bold",sans-serif;
font-style:normal'>[</span></b></span><span class=BillLanguage><span
style='font-style:normal'>a pre-filled auto-injector</span></span><span
class=BillLanguage><b><span style='font-family:"Albertus Extra Bold",sans-serif;
font-style:normal'>]</span></b></span><span class=BillLanguage><span
style='font-style:normal'> <u>an FDA</u> <u>approved</u> mechanism to a pupil
for anaphylaxis when the nurse is not physically present at the scene.  In the
event that a licensed athletic trainer volunteers to administer epinephrine, it
shall not constitute a violation of the &quot;Athletic Training Licensure
Act,&quot; P.L.1984, c.203 (C.45:9-37.35 et seq.).</span></span></p>

<p class=MsoNormal style='line-height:150%'><span class=BillLanguage><span
style='font-style:normal'>     Except as otherwise provided pursuant to
subsection f. of section 1 of P.L.1997, c.368 (C.18A:40-12.5), the school nurse
shall determine that:</span></span></p>

<p class=MsoNormal style='line-height:150%'><span class=BillLanguage><span
style='font-style:normal'>     a.     the designees have been properly trained
in the administration of the epinephrine via </span></span><span
class=BillLanguage><b><span style='font-family:"Albertus Extra Bold",sans-serif;
font-style:normal'>[</span></b></span><span class=BillLanguage><span
style='font-style:normal'>a pre-filled auto-injector</span></span><span
class=BillLanguage><b><span style='font-family:"Albertus Extra Bold",sans-serif;
font-style:normal'>]</span></b></span><span class=BillLanguage><span
style='font-style:normal'> <u>an FDA approved</u> mechanism using standardized
training protocols established by the Department of Education in consultation
with the Department of Health;</span></span></p>

<p class=MsoNormal style='line-height:150%'><span class=BillLanguage><span
style='font-style:normal'>     b.    the parents or guardians of the pupil
consent in writing to the administration of the epinephrine via </span></span><span
class=BillLanguage><b><span style='font-family:"Albertus Extra Bold",sans-serif;
font-style:normal'>[</span></b></span><span class=BillLanguage><span
style='font-style:normal'>a pre-filled auto-injector</span></span><span
class=BillLanguage><b><span style='font-family:"Albertus Extra Bold",sans-serif;
font-style:normal'>]</span></b></span><span class=BillLanguage><span
style='font-style:normal'> <u>an</u> <u>FDA approved</u> mechanism by the
designees;</span></span></p>

<p class=MsoNormal style='line-height:150%'><span class=BillLanguage><span
style='font-style:normal'>     c.     the board or chief school administrator
of a nonpublic school informs the parents or guardians of the pupil in writing
that the district and its employees or agents or the nonpublic school and its
employees and agents shall have no liability as a result of any injury arising
from the administration of the epinephrine to the pupil;</span></span></p>

<p class=MsoNormal style='line-height:150%'><span class=BillLanguage><span
style='font-style:normal'>     d.    the parents or guardians of the pupil sign
a statement acknowledging their understanding that the district or nonpublic
school shall have no liability as a result of any injury arising from the
administration of the epinephrine via </span></span><span class=BillLanguage><b><span
style='font-family:"Albertus Extra Bold",sans-serif;font-style:normal'>[</span></b></span><span
class=BillLanguage><span style='font-style:normal'>a pre-filled auto-injector</span></span><span
class=BillLanguage><b><span style='font-family:"Albertus Extra Bold",sans-serif;
font-style:normal'>]</span></b></span><span class=BillLanguage><span
style='font-style:normal'> <u>an</u> <u>FDA approved</u> mechanism to the pupil
and that the parents or guardians shall indemnify and hold harmless the
district and its employees or agents against any claims arising out of the
administration of the epinephrine via </span></span><span class=BillLanguage><b><span
style='font-family:"Albertus Extra Bold",sans-serif;font-style:normal'>[</span></b></span><span
class=BillLanguage><span style='font-style:normal'>a pre-filled auto-injector</span></span><span
class=BillLanguage><b><span style='font-family:"Albertus Extra Bold",sans-serif;
font-style:normal'>]</span></b></span><span class=BillLanguage><span
style='font-style:normal'>  <u>an</u> <u>FDA approved</u> mechanism to the
pupil; and</span></span></p>

<p class=MsoNormal style='line-height:150%'><span class=BillLanguage><span
style='font-style:normal'>     e.     the permission is effective for the
school year for which it is granted and is renewed for each subsequent school
year upon fulfillment of the requirements in subsections a. through d. of this
section.</span></span></p>

<p class=MsoNormal style='line-height:150%'><span class=BillLanguage><span
style='font-style:normal'>     The Department of Education, in consultation
with the Department of Health, shall require trained designees for students
enrolled in a school who may require the emergency administration of
epinephrine for anaphylaxis when the school nurse is not available.</span></span></p>

<p class=MsoNormal style='line-height:150%'><span class=BillLanguage><span
style='font-style:normal'>     Nothing in this section shall be construed to
prohibit the emergency administration of epinephrine via </span></span><span
class=BillLanguage><b><span style='font-family:"Albertus Extra Bold",sans-serif;
font-style:normal'>[</span></b></span><span class=BillLanguage><span
style='font-style:normal'>a pre-filled auto-injector</span></span><span
class=BillLanguage><b><span style='font-family:"Albertus Extra Bold",sans-serif;
font-style:normal'>]</span></b></span><span class=BillLanguage><span
style='font-style:normal'>  <u>an FDA approved</u> mechanism to a pupil for anaphylaxis
by the school nurse or other employees designated pursuant to this section when
the pupil is authorized to self-administer epinephrine pursuant to section 1 of
P.L.1993, c.308 (C.18A:40-12.3), or when there is a coexisting diagnosis of
asthma, or when a prescription is received from a licensed health care
professional for epinephrine coupled with another form of medication, or when
the epinephrine is administered pursuant to subsection f. of section 1 of
P.L.1997, c.368 (C.18A:40-12.5).</span></span></p>

<p class=MsoNormal style='line-height:150%'><span class=BillLanguage><span
style='font-style:normal'>(cf: P.L.2015, c.13, s.2)</span></span></p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     3. This act shall take effect
immediately.<br clear=all style='page-break-before:always'>
</p>

<p class=MsoNormal align=center style='text-align:center;line-height:150%'>STATEMENT</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     This bill modifies current law
regulating the method in which epinephrine is administered in schools during
emergency circumstances where a pupil is experiencing anaphylaxis. 
Specifically, the bill amends current law requiring <span class=BillLanguage><span
style='font-style:normal'>the use of a pre-filled auto-injector mechanism to
administer epinephrine in a school setting to allow any FDA approved
epinephrine administration mechanism to be used during an in-school anaphylaxis
emergency.</span></span></p>

</div>

</body>

</html>
